Recent Updates
Recently added Catalysts
VTRS Positive Sentiment

Viatris Announces Third Quarter 2024 Dividend Viatris Inc. (NASDAQ: VTRS) today announced that on November 4, 2024, its Board of Directors declared a quarterly dividend of $0.12 per share for...

Key Takeaway: Viatris Inc. (NASDAQ: VTRS) has declared a quarterly dividend of $0.12 per share, payable on December 13, 2024, to shareholders recorded by November 22. The announcement highlights the company's ongoing commitment to shareholder returns and financial health. Viatris positions itself as a leading global healthcare provider, aiming to bridge the gap between generics and branded medications. With a mission to improve health access worldwide, Viatris serves approximately 1 billion patients annually.
Price reaction · baseline $11.45 (2024-11-04 close) · hit after-hours · 2 other VTRS headline(s) in the window, move may be shared
day 0 close · peak
+1.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Viatris announced a quarterly dividend of $0.12 per share, reflecting financial stability.
  • The company's mission emphasizes providing access to healthcare for diverse populations worldwide.
  • Viatris is recognized for its extensive portfolio and global reach, indicating robust operational capacity.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+38%
120-day peak, hindsight
Typical move
1.6%
average across 12 past catalysts
Lead asset
Mylan's insulin glargine
Phase 3 · Type 1 Diabetes

Full Press Release Details

PITTSBURGH , Nov. 5, 2024 /PRNewswire/ -- Viatris Inc . (NASDAQ: VTRS ) today announced that on November 4, 2024 , its Board of Directors declared a quarterly dividend of $0.12 per share for each issued and outstanding share of the Company's common stock. The dividend is payable on December 13, 2024 , to shareholders of record as of the close of business on November 22, 2024 .
Viatris Inc. (NASDAQ: VTRS ) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh , Shanghai and Hyderabad, India . Learn more at viatris.com and investor.viatris.com , and connect with us on LinkedIn , Instagram , YouTube and X (formerly Twitter).
Forward-Looking Statements

Frequently Asked Questions

What dividend did Viatris declare recently?

Viatris declared a quarterly dividend of $0.12 per share.

When is the Viatris dividend payment date?

The dividend is payable on December 13, 2024.

Who qualifies for the Viatris dividend?

Shareholders must be on record by November 22, 2024, to qualify.

What is Viatris' mission?

Viatris aims to empower people to live healthier at every life stage.

How many patients does Viatris serve annually?

Viatris provides medicines to approximately 1 billion patients each year.

Last updated: Nov 5, 2024